Posts

Postdoctoral research experience gets major boost at Pe...

Former Pennington Biomedical Research Center Executive Director Dr. Claude Bouch...

NIH scientists find treatment for rare genetic skin dis...

Researchers at the National Institutes of Health and their colleagues have ident...

New liver dialysis device shows potential to resolve li...

Amsterdam, June 1, 2023 – Acute-on-chronic liver failure (ACLF) occurs in 30% of...

Huntsman Cancer Institute May research highlights

Huntsman Cancer Institute research highlights shine the spotlight on new discove...

Improving immune checkpoint inhibitors’ anti-tumor resp...

Scientists at Tohoku University have discovered a novel approach that improves t...

AstraZeneca’s Imfinzi-Lynparza combo shows positive tri...

AstraZeneca announced favorable results for its Imfinzi and Lynparza combo in an...

J&J Files For Approval of Carvykti in Europe

Johnson & Johnson has reached another milestone in their competition with Bristo...

Bristol Myers’ data makes a case for earlier use of a b...

Bristol Myers’ Reblozyl has surpassed Epogen in treating anemia caused by myelod...

Mirati’s Phase III sitravatinib combo trial flops

Mirati had intended that its preliminary findings for sitravatinib would be used...

Lexicon Pharma’s Heart Failure Drug Receives FDA Nod

Sotagliflozin, a drug manufactured by Lexicon Pharmaceuticals (Lexicon) which is...

Amidst COVID vaccine supply cuts to Europe, Moderna exp...

As global demand for the COVID-19 vaccine plummets, the European Union has decid...

Valneva seeks Health Canada approval for chikungunya va...

The single-shot vaccine is intended for persons aged 18 years and above.

Roche Canada and pCPA conclude talks for Vabysmo eye th...

Vabysmo helps treat neovascular (wet) age-related macular degeneration (AMD) and...

Sun Pharma and Philogen sign licence agreement for anti...

Sun Pharma will commercialise Nidlegy in three countries to treat skin cancers.

Early signals suggest oral SERD’s potential for more br...

The company is presenting exploratory results at ASCO, which demonstrates new us...

US companies drive 2023 drug launches positioned for bl...

Notably, American pharmaceutical mega-cap companies take the lead, with 80% repr...